Prognostic Biomarker of Fertility-Preserving Hormonal Therapy Based on Multigene Panel Testing for Endometrial Cancer.

Cancer Sci · 2026 · PMC12775563 · PMID 41208314

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Conversely, patients with CTNNB1 mutations exhibited a shorter duration until tumor disappearance and showed a trend toward higher initial CR rates in the overall population.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.